No single calprotectin level reliably confirms or rules out cancer on its own. The most widely used threshold in clinical research is 50 µg/g of stool, and roughly four out of five people later diagnosed with colorectal cancer exceed that mark before diagnosis. But that same cutoff is tripped by inflammatory bowel disease, certain medications, and even healthy aging, which is why the test works better as a triage tool than as a standalone diagnosis. The relationship between calprotectin and cancer is real, but the number on your lab report needs context to mean anything useful.
What the 50 µg/g Cutoff Actually Tells You
Most laboratories flag a fecal calprotectin (FC) result as “elevated” at 50 µg/g. That threshold was not chosen specifically for cancer detection; it was originally established to separate inflammatory gut conditions from functional ones like irritable bowel syndrome. Still, it performs reasonably well as a first-pass screen for colorectal cancer. In one diagnostic accuracy study of patients referred with suspected colorectal cancer, an FC cutoff of 50 µg/g was used to calculate sensitivity, specificity, and predictive values for both cancer and broader organic bowel disease.1British Journal of General Practice. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study A systematic review and meta-analysis found that colorectal cancer patients were about five times more likely than healthy controls to have an elevated FC result.2PubMed Central. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis
A recent review summarized the broader literature by noting that FC shows high sensitivity but only moderate specificity for colorectal tumors.3PubMed Central. Research progress on the diagnostic value of fecal calprotectin in colorectal tumors In plain terms, the test is good at catching cancer when it is there, but it also lights up for plenty of conditions that are not cancer. That gap between sensitivity and specificity is the core reason calprotectin alone cannot answer the question “do I have cancer?” It can, however, tell a doctor that something inflammatory is going on in your gut and that further investigation, usually a colonoscopy, is warranted.
How Tumor Stage and Location Shift the Numbers
Calprotectin levels are not the same across all colorectal cancers. A retrospective study of patients with confirmed colorectal cancer found that FC correlated positively with tumor stage: more advanced cancers (stage III and IV) were associated with higher readings. In that study, about 79% of all colorectal cancer patients had FC at or above 50 µg/g, but the odds of being above that threshold were roughly three and a half times higher for stage III/IV tumors compared with earlier-stage disease. At a higher cutoff of 100 µg/g, advanced-stage disease still predicted elevation.4PubMed Central. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
Tumor location matters too. In the same study, patients with right-sided colon cancers were significantly more likely to have FC above 50 µg/g than those with left-sided cancers (92% versus 74%). Right-sided tumors sit further from the rectum, and the stool spends more time in contact with them as it passes through, which likely drives greater calprotectin release. This location effect is worth knowing because right-sided cancers are also the ones most often missed by other screening methods like the fecal immunochemical test (FIT), which relies on detecting blood rather than inflammatory proteins.4PubMed Central. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
All of this suggests that very high readings, particularly above 100 µg/g, should prompt more urgency, while a level just over 50 µg/g in someone with no other red flags may warrant watchful reassessment rather than immediate alarm. But the overlap between stages is wide, and no calprotectin level can substitute for imaging or biopsy when staging a known or suspected tumor.
What Else Pushes Calprotectin Up
Calprotectin is released by white blood cells called neutrophils whenever they accumulate in the gut lining. Cancer is just one of many reasons that happens. Inflammatory bowel disease, both Crohn’s disease and ulcerative colitis, routinely produces FC levels in the hundreds or even thousands. As one gastroenterology group noted, while calprotectin is useful for ruling out organic disease when it comes back low, an elevated result is not specific to IBD or to cancer; it simply signals that something is inflaming the intestinal wall.5American Journal of Gastroenterology. Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease
Diverticular disease is another common culprit. Patients with acute uncomplicated diverticulitis and even those with symptomatic but uncomplicated diverticular disease showed significantly higher FC levels than healthy controls and irritable bowel syndrome patients in a case-control study.6International Journal of Colorectal Disease. Faecal calprotectin in colonic diverticular disease: a case-control study Upper gastrointestinal inflammation can also drive calprotectin up; one comparative study found levels as high as 600 µg/g in a patient with duodenitis.7Wisdom Journal For Studies & Research. A Comparative Study of Fecal Calprotectin Levels and Occult Blood in Different Inflammatory Conditions of the Digestive System Infections, celiac disease, and even gut reactions to food intolerances can elevate the marker to varying degrees.
Medications are a particularly underappreciated confounder. An observational study of patients diagnosed with functional bowel disorders (conditions where no structural disease exists) found that those prescribed proton pump inhibitors (PPIs) had median FC levels almost three times higher than patients not on PPIs, and NSAID users showed a similar pattern.8PubMed. Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study A separate study in patients with ankylosing spondylitis confirmed that NSAID use independently raised FC.9PubMed. Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin If you are taking ibuprofen, naproxen, aspirin, or a PPI like omeprazole, your calprotectin result may be inflated by the medication itself rather than by any disease process. Some clinicians ask patients to stop NSAIDs for a week or two before retesting, though this is not universally standardized.
Age Changes the Baseline
Your “normal” calprotectin level depends quite a bit on how old you are. A study of healthy adults with no gastrointestinal disease found that the average FC concentration was about 16 µg/g in people under 50, rose to about 35 µg/g between the ages of 50 and 69, and jumped to roughly 160 µg/g in people over 70.10Korean Journal of Clinical Laboratory Science. Age-Related Fecal Calprotectin Concentrations in Healthy Adults That last figure is well above the standard 50 µg/g cutoff, meaning a perfectly healthy 75-year-old could easily get a result that triggers further workup.
Children present the opposite problem. Infants have dramatically higher calprotectin than older children or adults, and toddlers remain elevated for years. One large study found that 47% of pediatric samples exceeded the standard adult reference level of 50 µg/g, with infants showing the highest averages and levels gradually declining into the school-age years.11PubMed Central. Guidance on the interpretation of faecal calprotectin levels in children Pediatric cancer is extremely rare in comparison to adult colorectal cancer, so these elevated readings almost never indicate malignancy in children. The takeaway is that using a flat 50 µg/g threshold for all ages leads to a lot of false positives in the very young and the elderly.
Some researchers have called for age-adjusted reference ranges. A 70-year-old with a calprotectin of 80 µg/g might be entirely normal for their age, while the same result in a 30-year-old would be more meaningful. In practice, most labs still report against the same 50 µg/g cutoff regardless of age, so this context often has to come from the doctor interpreting the result.
Calprotectin and Upper GI Cancers
Most research on calprotectin and cancer focuses on colorectal tumors, but the marker may also have a role in detecting cancers of the esophagus and stomach. A study comparing patients with confirmed esophago-gastric cancer to cancer-free controls found that the median FC level in cancer patients was 97 µg/g, compared with less than 20 µg/g in controls. At the standard 50 µg/g cutoff, the test showed a sensitivity of about 77% and a specificity of 88% for these upper GI cancers.12PubMed. Faecal calprotectin as a marker for oesophago-gastric cancer
Those numbers are surprisingly strong for a stool test detecting cancers that are anatomically far from the colon. The mechanism is thought to involve inflammatory proteins shed by the tumor draining into the intestinal lumen as the contents of the stomach move downward. This area remains relatively understudied, but it raises the possibility that a high calprotectin result in someone without obvious colonic disease could occasionally point to an upper gastrointestinal malignancy that otherwise might not be investigated until symptoms become more advanced.
Pairing Calprotectin With Other Stool Tests
Given calprotectin’s limitations as a solo test, researchers have investigated what happens when you combine it with a fecal immunochemical test (FIT), which detects hidden blood in the stool. The logic is straightforward: FIT catches bleeding lesions well but can miss non-bleeding tumors, while calprotectin picks up inflammation regardless of whether blood is present. Together, they cover more ground.
One study found that adding a calprotectin cutoff of 150 µg/g to the standard FIT blood threshold improved sensitivity for colorectal cancer detection.13PubMed Central. Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study Another analysis of symptomatic patients found that combining a fecal occult blood test with calprotectin produced a negative predictive value above 94%, meaning that when both tests come back normal, the chance of having significant bowel disease is very low. That combination also allowed nearly 40% of colonoscopies to be avoided while cutting total diagnostic costs by about a fifth.14PubMed Central. The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
A separate study looked at how well different tests performed in patients with chronic lower GI symptoms. FIT outperformed calprotectin when used alone, but combining both stool tests with clinical “alarm features” like unexplained weight loss or rectal bleeding improved diagnostic precision. Patients without alarm features who tested negative on both FIT and FC at low thresholds had a negative predictive value of 97%, and no cancers were missed in that group.15PubMed Central. Evaluating the Efficacy of Fecal Immunochemical Test, Fecal Calprotectin, and Serum C-Reactive Protein in Diagnosing Patients With Chronic Lower Gastrointestinal Symptoms The evidence is building that calprotectin’s best use in cancer detection is not as a standalone alarm bell, but as part of a panel that, taken together, can either reassure you that colonoscopy is not urgent or flag that it should happen soon.
Calprotectin Levels After Cancer Surgery
If you have already been treated for a gastrointestinal cancer, an elevated calprotectin reading in the months after surgery does not necessarily mean the cancer has returned. A study comparing post-operative patients found that more than half of those who had esophago-gastric surgery had FC levels above 50 µg/g, compared with about a quarter of those who had a hemicolectomy (removal of part of the colon). Median levels in both groups hovered around 96 to 99 µg/g, but the proportion exceeding the threshold varied by procedure type. Patients who had a Roux-en-Y bypass, which reroutes the digestive tract, showed significantly higher levels than those who had left-sided colon resections.16Oxford Academic / Journal of Surgical Case Reports. Elevated fecal calprotectin values appear more common following esophagogastric than colon surgery
The surgical rearrangement of the gut itself causes low-grade inflammation that can persist for months, and this drives calprotectin up independently of any residual or recurrent disease. For patients being monitored after cancer treatment, the practical message is that a single elevated reading should be interpreted alongside imaging and clinical symptoms rather than being treated as proof of recurrence. Surgeons and oncologists increasingly recognize this pitfall, though many patients understandably find it anxiety-provoking to see a flagged result on their post-treatment labs.
Practical Considerations for Accurate Testing
Before worrying about what your number means, it helps to know that sample handling has been shown to have relatively little impact on calprotectin results. A study examining different stool consistencies and pre-analytical treatments found no statistically significant differences in measurement bias between solid, semi-solid, and liquid samples across two major assay platforms.17PubMed Central. Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability This is reassuring: a loose stool from a nervous morning or a firmer sample from a different day should not dramatically change the clinical picture.
What can change the picture, as discussed above, are medications. If you are taking NSAIDs or PPIs and your calprotectin comes back elevated, your doctor may want to repeat the test after stopping the medication for a couple of weeks, rather than jumping straight to colonoscopy. Similarly, recent gastrointestinal infections or courses of antibiotics can temporarily push the marker up, so timing matters.
One underappreciated nuance is the relationship between calprotectin and C-reactive protein (CRP), the blood marker of systemic inflammation. In colorectal cancer patients, FC correlates positively with CRP and negatively with hemoglobin, meaning that patients with higher calprotectin tend to also have higher systemic inflammation and lower red blood cell counts.4PubMed Central. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study Checking these together gives a doctor a richer picture than any single value offers. A calprotectin of 120 µg/g alongside normal CRP and hemoglobin paints a very different clinical story than the same calprotectin alongside elevated CRP and anemia. Context, as with almost everything about this marker, is doing most of the diagnostic work.